Stacked Bar Plot from Scientific Research

Pancreatic tumor incidence 5.5 weeks post-implantation in OVA-expressing tumor-bearing mice following OT-I CD8+T cell adoptive transfer and no treatment or RT, PD1-IL2v, or RT + PD1-IL2v treatment. Mice were orthotopically implanted with PK5L1940 OVA-expressing cells. PD1-IL2v was dosed once per week beginning day 7 post-implantation. All tissue was collected 39 days post-implantation; n ≥ 5 per group. Data are represented as mean ± SEM. The p values were calculated with Student’s t test,*p < 0.05,**p < 0.01,***p < 0.001,****p < 0.0001. See also Figure S5.

DOI